SCPH (scPharmaceuticals Inc.) Earnings per share growth rate in current year
Is it worth investing in scPharmaceuticals Inc. (SCPH), given the risks of electronics supply chain disruptions and logistical barriers? The annual growth rate of net income per share provides the answer, with the value holding at 41.60. scPharmaceuticals Inc. (SCPH) develops wearable systems for heart failure patients, reducing hospitalizations. The FDA-approved, patented Furoscix patch creates a robust defensive barrier against generics.
Analytical breakdowns and data insights for company scPharmaceuticals (SCPH)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
Total Debt to Equity Ratio scPharmaceuticals Inc.|SCPH - Long-Term Debt to Equity|Current Liabilities to Equity scPharmaceuticals, Inc.|SCPH - Company Aggregate Debts|Debt to Net Assets Ratio scPharmaceuticals|SCPH - Company Long-Term Debts|Company Short-Term Debts scPharmaceuticals|Intermediate Coverage Ratio scpharmaceuticals.com
- net income and valuation multiples indicators:
SCPH - Company Net Income|Future Profit scPharmaceuticals Inc.|SCPH - P/E Multiple|Forward P/E Multiple scPharmaceuticals, Inc.|SCPH - PEG Multiple|Enterprise Value to EBITDA Ratio scPharmaceuticals|SCPH - Operating profit EBITDA|Net earnings per one share for the last twelve months scPharmaceuticals|SCPH - Net earnings per share for the last 12 months|Quarterly EPS earnings growth scpharmaceuticals.com|SCPH - Net earnings per share growth this year|Projected earnings per share increase next year scPharmaceuticals Inc.
- revenue and sales proceeds data:
Fundamental valuation:scPharmaceuticals Inc. (SCPH)
For the biotech sector company scPharmaceuticals Inc. (SCPH), this indicator serves as a measure of the efficiency of innovation capitalization, accounting for the costs of implementing sustainable closed-loop production cycles. By analyzing the volatility of annual earnings per share, an investor assesses the percentage shift in annual net income, which allows for the exclusion of seasonality and the rapid diagnosis of risks related to liquidity contraction or asset yield stagnation.
Direct competitors
Earnings per share growth rate in current year Haleon Corp (HLN)|KVUE (Kenvue Inc) - Earnings growth in current year|Earnings per share growth rate in current year veronapharma.com VRNA|Earnings per share growth in current year Jyong Biotech (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal Pharmaceuticals, Inc.)|PRGO (Perrigo Company) - Earnings per share trend in current year|ALVO - Earnings per share growth in current year|Expected net earnings per share growth this year liquidia.com LQDA|Galapagos (GLPG) - Earnings per share growth in current year|ANIP - Expected net earnings per share growth this year|Earnings per share growth in current year MannKind Corporation|AMPH: Earnings per share increase in current year|Earnings per share growth in current year Pacira BioSciences (PCRX)|SPRY: Earnings per share trend in current year|Theravance Biopharma, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year AQST (Aquestive Therapeutics, Inc.)|Tectonic Therapeutic Inc. - Earnings growth in current year|Earnings per share trend in current year TNXP|SXTC (China SXT Pharmaceuticals) - Net earnings per share growth this year|Eupraxia Pharmaceuticals (EPRX) - Earnings growth in current year|Earnings per share growth in current year BioHarvest Sciences, Inc.|EXOZ: Earnings per share increase in current year|Earnings growth in current year ORMP|ENTX - Earnings per share growth rate in current year|Earnings per share growth in current year MindWalk Holdings, Inc. HYFT|Earnings growth in current year abvcpharma.com ABVC|CPIX - Earnings per share growth in current year|Earnings per share trend in current year QNTM|FGEN (FibroGen Corporation) - Net earnings per share growth this year|Net earnings per share growth this year Telomir Pharma|Net earnings per share growth this year RANI|Earnings per share growth rate in current year synergychc.com SNYR|Earnings per share growth in current year Rallybio Corp (RLYB)|LEXX - Earnings per share growth rate in current year|Pulmatrix Inc - Net earnings per share growth this year|Earnings per share increase in current year PTHL|Aptorum Group Ltd - Earnings growth in current year|Expected net earnings per share growth this year Lyra Therapeutics LYRA|IBO: Earnings growth in current year|TNFA (TNF Pharma) - Earnings per share growth in current year|Earnings per share growth in current year cbdmd.com|Earnings per share growth this year PRFX (PainReform Corp)|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharmaceuticals LIPO|Earnings per share growth in current year OptiNose OPTN|Pieris Pharmaceuticals Inc - Earnings per share growth in current year|Procaps Group Corp - Earnings growth in current year|Expected net earnings per share growth this year Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN (SLRN) - Earnings growth in current year|Earnings per share growth in current year TFF Pharmaceuticals
